Posts by: Stacy Grieve, PhD

News

Researchers at Boston’s Joslin Diabetes Center have developed a prognostic tool that predicts the risk of end-stage renal disease (ESRD) in patients with type 1 or type 2 diabetes. “Overall efficiency and ... Read more

April 5, 2017

FDA to Review Auryxia for Patients with CKD and Iron Deficiency Anemia

News

Keryx Biopharmaceuticals’ drug Auryxia (ferric citrate) will undergo a review by the U.S. Food and Drug Administration (FDA) to expand its clinical indications to include non-dialysis dependent chronic kidney disease (NDD-CDK) ... Read more

February 8, 2017

Higher Serum Levels of Klotho Protein May Protect Kidney Function, Study Finds

News

Higher levels of the klotho protein may protect the kidney from declining function, a new study reports. These findings suggest that klotho may serve as a potential therapeutic target for the ... Read more